EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Managing Asthma Well and Sustainably – Patient Perspectives Explored

Imogen Le Couteur, Sean Docking, Katy Bell, Alexandra Barratt, Rebecca Haddock, Darlene Cox, Kate Wylie, Luise Kazda iD

Health Expectations · 2026-08 · 29 (4)

DOI: 10.1111/hex.70751 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Health Expectations, online erschienen am 03.07.2026. Verfasst von Imogen Le Couteur und 7 weiteren Autor:innen. Beteiligte Einrichtung: Wiser Healthcare Research Collaboration, Sydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Austr…. Hauptthemen laut MEDLINE: Asthma, Adrenergic beta-2 Receptor Agonists, Patient Preference. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council (NHMRC) HEAL Network Innovation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Asthma affects 300 million people worldwide. The widespread use of short‐acting beta 2 ‐agonist (SABA) relievers, commonly delivered via pressurised metered dose inhalers (pMDIs), is contrary to evidence‐based guidelines. SABA overuse is associated with poor asthma control and high carbon emissions. Reducing reliance presents a dual opportunity to improve patient outcomes while decreasing environmental impact, yet patient perspectives remain unclear.

Objective

The aim of this study was to explore the perspectives, understanding, and preferences of a sample of Australians living with asthma regarding inhaler types, medication options, self‐management, and environmental impact.

Methods

We conducted in‐depth interviews with adults who regularly used inhalers to manage their asthma ( n = 23), recruited via consumer health networks. Participants completed an online pre‐interview survey on demographics, asthma history and inhaler use. Interviews were semi‐structured, following a guide developed with advice from the consumer panel. Data were analysed thematically using an inductive framework. Survey data were summarised descriptively.

Results

Predominantly female (91%) participants had limited awareness of different device types and their environmental impact, with many surprised by pMDI emissions. While most valued environmental sustainability, they prioritised access to fast‐acting SABA pMDIs, perceived to be the most effective emergency treatment by many. Familiarity, psychological comfort, and concern about reliable relief during acute asthma attacks were key barriers to switching device types. Health professional recommendation strongly influenced choice of inhaler, with most participants relying on clinician advice and expressing limited involvement in decision‐making. Barriers to accessing care and information, such as cost, time and rurality, contributed to knowledge gaps and potential overreliance on SABAs. Positive experiences with asthma care nurses and pharmacists highlighted opportunities for multi‐disciplinary care teams to improve support.

Conclusion

Environmental concern is important to patients but, alone, is insufficient to drive change in asthma management. Treatment is shaped by familiarity, habit and fear of exacerbations, with strong reliance on clinician expertise. Patient and Public Contributions A consumer panel of asthma patients provided lived‐experience insights during study conception, helped shape interview materials, and reviewed our findings and conclusions. Asthma Australia (Australia's peak asthma consumer advocacy body) and the Health Care Consumers' Association were engaged in this project since inception of the study idea, collaborated in co‐designing the funding proposal, recruiting participants and their representatives contributed to the research as co‐authors. Their involvement ensures our research reflects real‐world experiences and perspectives.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AsthmaAdrenergic beta-2 Receptor AgonistsPatient PreferenceHumansFemaleMaleAdultMiddle AgedAustraliaInterviews as TopicAgedNebulizers and VaporizersHealth Knowledge, Attitudes, PracticeMetered Dose InhalersYoung Adult

Stichwörter der Autor:innen

asthmaevidence‐based medicinegeneral practicepatient perspectivesqualitative methodsrespiratory inhalersshared decision making

Substanzen

Adrenergic beta-2 Receptor Agonists

Autor:innen und Institutionen

  • Wiser Healthcare Research Collaboration, Sydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.
  • Musculoskeletal Health and Wiser Health Care Units, School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.
  • Asthma Australia, Sydney, NSW, Australia.
  • HealthCare Consumers' Association, Canberra, ACT, Australia.
  • Doctors for the Environment Australia, Melbourne, VIC, Australia.
  • HEAL Global Research Centre, University of Canberra, Canberra, ACT, Australia.

ORCID-Profile: Luise Kazda

Förderung

  • National Health and Medical Research Council (NHMRC) HEAL Network Innovation

Zitieren

APA

Couteur, I. L., Docking, S., Bell, K., Barratt, A., Haddock, R., Cox, D., Wylie, K., & Kazda, L. (2026). Managing Asthma Well and Sustainably – Patient Perspectives Explored. Health Expectations, 29(4). https://doi.org/10.1111/hex.70751

Vancouver

Couteur IL, Docking S, Bell K, Barratt A, Haddock R, Cox D, et al. Managing Asthma Well and Sustainably – Patient Perspectives Explored. Health Expectations. 2026;29(4). doi:10.1111/hex.70751

BibTeX
@article{Couteur2026,
  author = {Couteur, Imogen Le and Docking, Sean and Bell, Katy and Barratt, Alexandra and Haddock, Rebecca and Cox, Darlene and Wylie, Kate and Kazda, Luise},
  title = {Managing Asthma Well and Sustainably – Patient Perspectives Explored},
  journal = {Health Expectations},
  year = {2026},
  volume = {29},
  number = {4},
  doi = {10.1111/hex.70751}
}
Kostenlos starten →